OECT Biosensor with AC Electrothermal Flow for Rapid Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biomolecular diagnostic methods for detecting diseases such as HIV, Ebola, and COVID-19 are limited by labor-intensive sample preparation, long turn-around times, and reduced sensitivity due to complex sample handling and transportation.
Innovation Solution
The development of OECT-based immunosensors with a biorecognition layer formed through a biological autocatalytic coupling strategy, eliminating the need for organic molecule self-assembled monolayers, allows for rapid and sensitive detection of analytes in raw, unprocessed samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods (RRT-PCT, RT-PCR) are used, then sensitivity can be achieved, but sample preparation time and complexity increase significantly
Solution Approach 1:
The invention extracts and eliminates the complex sample preparation steps (amplification, RNA extraction) from the detection workflow. The OECT-based immunosensor directly detects biomarkers in raw, unprocessed samples by removing the need for labor-intensive laboratory procedures, thereby reducing preparation time while maintaining detection capability through the transistor's high sensitivity to biomarker binding events.
Solution Approach 2:
The invention replaces mechanical/sample handling operations (pipetting, centrifugation, extraction) with an electrical detection system. The OECT transistor converts biomarker binding events directly into measurable electrical signals, substituting mechanical sample processing with an electrical field-based detection mechanism that requires minimal sample preparation.
2Ease of operation
If complex sample handling and transportation are performed, then samples can be tested, but clinical sensitivity decreases and false-negative results increase
Solution Approach 1:
The OECT-based immunosensor enables direct detection in raw samples without requiring external sample processing infrastructure. The device itself performs the detection function without needing complex sample handling, transportation, or preparation steps, thereby eliminating sources of sensitivity loss and false negatives while maintaining operational simplicity.
Solution Approach 2:
The invention performs detection action before sample processing can cause sensitivity loss. By enabling direct detection in raw samples, the system captures biomarkers in their native state before any handling-induced degradation or loss occurs, thereby preserving clinical sensitivity and eliminating false negatives.
3Productivity
If manual pipetting is used to accelerate protein transport, then detection speed improves, but operation complexity and labor intensity increase
Solution Approach 1:
The invention replaces manual mechanical pipetting with an automated electrical detection system. The OECT transistor uses electrical fields to facilitate biomarker binding and detection, eliminating the need for manual pipetting operations while maintaining rapid detection capability through the transistor's inherent sensitivity and automated signal measurement.
Solution Approach 2:
The OECT-based system performs detection automatically without requiring manual intervention for sample manipulation. The transistor self-regulates the detection process through electrical field effects, eliminating labor-intensive pipetting steps while maintaining high detection speed through automated electrical signal measurement and analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces incubation time, enhances sensitivity, and improves the accuracy of biomolecular diagnostics, enabling rapid detection of pathogens like SARS-CoV-2 in complex bodily fluids with high specificity and low background noise.
Implementation Method 1
The biorecognition layer is configured to bind to the analyte, thereby modulating the channel current
Implementation Method 2
The channel is formed from a conducting polymer and electronically connects the source electrode and the drain electrode
Data Source
AI summary
Devices and methods of analyte detection using AC electrokinetic/electrohydrodynamic forces combined with an OECT-based immunosensor are disclosed. An analyte binding agent, for example, a nanobody-functionalized organic electrochemical transistor (OECT) is incorporated with the micro-stirring effect of alternating current electrothermal flow (ACET) for the ultrarapid detection of single-molecule-to-nanomolar levels of the analyte. The ACET flow is induced by a biased AC electrical field can rapidly convect the analyte onto concentric gate electrodes within a minute, and the analyte is captured via recognition units that bind the analyte binding agent while sweeping nonspecific ally bound analyte away from the surface.